BML-277Chk2 inhibitor,potent and highly selective CAS# 516480-79-8 |
Related Products
- LY2606368
Catalog No.:BCC4105
CAS No.:1234015-52-1
- AZD7762
Catalog No.:BCC2555
CAS No.:860352-01-8
- MK-8776 (SCH-900776)
Catalog No.:BCC3817
CAS No.:891494-63-6
- LY2603618
Catalog No.:BCC3923
CAS No.:911222-45-2
- PF-477736
Catalog No.:BCC4421
CAS No.:952021-60-2
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 516480-79-8 | SDF | Download SDF |
| PubChem ID | 9969021 | Appearance | Powder |
| Formula | C20H14ClN3O2 | M.Wt | 363.8 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | Chk2 Inhibitor II; C 3742 | ||
| Solubility | DMSO : 22.22 mg/mL (61.08 mM; Need ultrasonic) | ||
| Chemical Name | 2-[4-(4-chlorophenoxy)phenyl]-3H-benzimidazole-5-carboxamide | ||
| SMILES | C1=CC(=CC=C1C2=NC3=C(N2)C=C(C=C3)C(=O)N)OC4=CC=C(C=C4)Cl | ||
| Standard InChIKey | UXGJAOIJSROTTN-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C20H14ClN3O2/c21-14-4-8-16(9-5-14)26-15-6-1-12(2-7-15)20-23-17-10-3-13(19(22)25)11-18(17)24-20/h1-11H,(H2,22,25)(H,23,24) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.In Vitro:BML-277 is an ATP-competitive inhibitor of Chk2 that dose dependently protects human CD4+ and CD8+ T-cells from apoptosis due to ionizing radiation. BML-277 efficiently rescues both T-cell populations from radiation-induced apoptosis in a dose-dependent manner with an observed EC50 of 3−7.6 μM. The concentration of BML-277 required for radioprotection is consistent with the biochemical measurement of chk2 inhibition. Providing theKm of ATP for Chk2 is determined to be 99 μM and the Ki for BML-277 is 37 nM, and assuming that the intracellular ATP concentration is 10 mM, a 5 μM concentration of BML-277 would be expected to produce 42% inhibition of intracellular chk2[1]. References: | |||||
BML-277 Dilution Calculator
BML-277 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7488 mL | 13.7438 mL | 27.4876 mL | 54.9753 mL | 68.7191 mL |
| 5 mM | 0.5498 mL | 2.7488 mL | 5.4975 mL | 10.9951 mL | 13.7438 mL |
| 10 mM | 0.2749 mL | 1.3744 mL | 2.7488 mL | 5.4975 mL | 6.8719 mL |
| 50 mM | 0.055 mL | 0.2749 mL | 0.5498 mL | 1.0995 mL | 1.3744 mL |
| 100 mM | 0.0275 mL | 0.1374 mL | 0.2749 mL | 0.5498 mL | 0.6872 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
BML-277 is novel, potent and highly selective inhibitor of the chk2 with the IC50 value of 15±6.9nM [1].
BML-277 has shown the ATP-competitive inhibition of chk2 with the Ki value of 37nM. BML-277 has also been exhibited to be a chk2 inhibitor with the IC50 value of 15±6.9nM and efficiently rescue T-cell populations from the apoptosis of radiation-induced in a concentration-dependent fashion with the EC50 of 3~7.6μM. The Km of ATP for chk2 is 99μM and assuming that intracellular ATP concentration is 10mM. Apart from these, BML-277 has shown the inhibition through docking into a homology model of chk2 ATP binging site [1].
References:
[1]Arienti KL1, Brunmark A, Axe FU, McClure K, Lee A, Blevitt J, Neff DK, Huang L, Crawford S, Pandit CR, Karlsson L, Breitenbucher JG. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem. 2005 Mar 24;48(6):1873-85.
Featured Products
- Z-D-Glu(OtBu)-OH
Catalog No.:BCC2771
CAS No.:51644-83-8
- 20(S)-Hydroxycholesterol
Catalog No.:BCC7937
CAS No.:516-72-3
- Allopregnanolone
Catalog No.:BCC7737
CAS No.:516-54-1
- Cerevisterol
Catalog No.:BCN5640
CAS No.:516-37-0
- Taurochenodeoxycholic Acid
Catalog No.:BCN8419
CAS No.:516-35-8
- Methylmalonate
Catalog No.:BCC7986
CAS No.:516-05-2
- Cuspidiol
Catalog No.:BCN3942
CAS No.:51593-96-5
- DMH4
Catalog No.:BCC6196
CAS No.:515880-75-8
- Neoechinulin A
Catalog No.:BCN5638
CAS No.:51551-29-2
- Flurizan
Catalog No.:BCC2342
CAS No.:51543-40-9
- Vitexin argininate
Catalog No.:BCC8179
CAS No.:51542-56-4
- GW 803430
Catalog No.:BCC7897
CAS No.:515141-51-2
New Products
- Murrangatin diacetate
Catalog No.:BCN5641
CAS No.:51650-59-0
- 2-Methoxyphenalen-1-one
Catalog No.:BCN7181
CAS No.:51652-39-2
- Erythrartine
Catalog No.:BCN5642
CAS No.:51666-26-3
- Kadsurin
Catalog No.:BCN3634
CAS No.:51670-40-7
- 2-Acetylbutyrolactone
Catalog No.:BCC8515
CAS No.:517-23-7
- Hematoxylin
Catalog No.:BCC5322
CAS No.:517-28-2
- Sennidin B
Catalog No.:BCN6355
CAS No.:517-44-2
- Corytuberine
Catalog No.:BCN2670
CAS No.:517-56-6
- Stephanine
Catalog No.:BCN5643
CAS No.:517-63-5
- Dicentrine
Catalog No.:BCN3296
CAS No.:517-66-8
- Shikonin
Catalog No.:BCN1006
CAS No.:517-88-4
- Shikonine
Catalog No.:BCN3530
CAS No.:517-89-5
BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor with an IC50 of 15 nM.
BML-277,516480-79-8,Chk2 Inhibitor II; C 3742,Natural Products,Chk, buy BML-277 , BML-277 supplier , purchase BML-277 , BML-277 cost , BML-277 manufacturer , order BML-277 , high purity BML-277
